Felix Biotechnology

About:

Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.

Website: https://www.felixbt.com/

Twitter/X: felixbiotech

Top Investors: Y Combinator, National Science Foundation, Bossanova Investimentos, Pioneer Fund, Small Business Innovation Research

Description:

Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases. Felix Biotechnology's bio-therapeutics targets antibiotic-resistant bacteria to manage infectious diseases precisely and effectively, allowing healthcare professionals to manage urgent microbial challenges in human health.

Total Funding Amount:

$720000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2019-01-16

Contact Email:

info(AT)felixbt.com

Founders:

Natalie Ma, Paul Turner, Robert McBride

Number of Employees:

1-10

Last Funding Date:

2022-07-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai